TSHA logo

Taysha Gene Therapies, Inc. (TSHA) Free Cash Flow

Annual FCF:

-$81.60M-$1.21M(-1.51%)
December 31, 2024

Summary

  • As of today, TSHA annual free cash flow is -$81.60 million, with the most recent change of -$1.21 million (-1.51%) on December 31, 2024.
  • During the last 3 years, TSHA annual free cash flow has risen by +$57.00 million (+41.12%).

Performance

TSHA Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAcash flow metrics

Quarterly FCF:

-$24.27M-$4.09M(-20.26%)
September 30, 2025

Summary

  • As of today, TSHA quarterly free cash flow is -$24.27 million, with the most recent change of -$4.09 million (-20.26%) on September 30, 2025.
  • Over the past year, TSHA quarterly free cash flow has dropped by -$2.62 million (-12.12%).
  • TSHA quarterly free cash flow is now -295.71% below its all-time high of $12.40 million, reached on December 31, 2022.

Performance

TSHA Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAcash flow metrics

TTM FCF:

-$85.14M-$2.62M(-3.18%)
September 30, 2025

Summary

  • As of today, TSHA TTM free cash flow is -$85.14 million, with the most recent change of -$2.62 million (-3.18%) on September 30, 2025.
  • Over the past year, TSHA TTM free cash flow has dropped by -$5.70 million (-7.17%).
  • TSHA TTM free cash flow is now -4911.42% below its all-time high of -$1.70 million, reached on March 31, 2020.

Performance

TSHA TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TSHA Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-1.5%-12.1%-7.2%
3Y3 Years+41.1%+23.7%+51.2%
5Y5 Years-100.0%--

TSHA Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1.5%+41.1%-295.7%+23.7%-64.2%+51.2%
5Y5-Year>-9999.0%+41.1%-295.7%+53.6%-209.2%+52.3%
All-TimeAll-Time>-9999.0%+41.1%-295.7%+53.6%-4911.4%+52.3%

TSHA Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$24.27M(-20.3%)
-$85.14M(-3.2%)
Jun 2025
-
-$20.18M(+9.9%)
-$82.52M(+1.8%)
Mar 2025
-
-$22.40M(-22.5%)
-$84.04M(-3.0%)
Dec 2024
-$81.60M(-1.5%)
-$18.29M(+15.5%)
-$81.60M(-2.7%)
Sep 2024
-
-$21.65M(+0.3%)
-$79.44M(-0.3%)
Jun 2024
-
-$21.70M(-8.8%)
-$79.24M(-3.9%)
Mar 2024
-
-$19.96M(-23.7%)
-$76.26M(+5.1%)
Dec 2023
-$80.39M(+29.0%)
-$16.13M(+24.8%)
-$80.39M(-55.0%)
Sep 2023
-
-$21.45M(-14.6%)
-$51.85M(+16.7%)
Jun 2023
-
-$18.72M(+22.3%)
-$62.23M(+26.8%)
Mar 2023
-
-$24.09M(-294.2%)
-$84.98M(+25.0%)
DateAnnualQuarterlyTTM
Dec 2022
-$113.26M(+18.3%)
$12.40M(+139.0%)
-$113.26M(+35.1%)
Sep 2022
-
-$31.83M(+23.2%)
-$174.44M(+2.3%)
Jun 2022
-
-$41.47M(+20.8%)
-$178.54M(-6.0%)
Mar 2022
-
-$52.37M(-7.4%)
-$168.39M(-21.5%)
Dec 2021
-$138.60M(-248.1%)
-$48.78M(-35.7%)
-$138.60M(-19.8%)
Sep 2021
-
-$35.94M(-14.8%)
-$115.66M(-45.1%)
Jun 2021
-
-$31.31M(-38.7%)
-$79.72M(-64.7%)
Mar 2021
-
-$22.57M(+12.7%)
-$48.41M(-75.8%)
Dec 2020
-$39.81M(>-9900.0%)
-
-
Dec 2020
-
-$25.84M(-1420.8%)
-$27.54M(-1520.8%)
Mar 2020
-
-$1.70M
-$1.70M
Dec 2019
$0.00
-
-

FAQ

  • What is Taysha Gene Therapies, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. annual free cash flow year-on-year change?
  • What is Taysha Gene Therapies, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. quarterly free cash flow year-on-year change?
  • What is Taysha Gene Therapies, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. TTM free cash flow year-on-year change?

What is Taysha Gene Therapies, Inc. annual free cash flow?

The current annual free cash flow of TSHA is -$81.60M

What is the all-time high annual free cash flow for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high annual free cash flow is $0.00

What is Taysha Gene Therapies, Inc. annual free cash flow year-on-year change?

Over the past year, TSHA annual free cash flow has changed by -$1.21M (-1.51%)

What is Taysha Gene Therapies, Inc. quarterly free cash flow?

The current quarterly free cash flow of TSHA is -$24.27M

What is the all-time high quarterly free cash flow for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high quarterly free cash flow is $12.40M

What is Taysha Gene Therapies, Inc. quarterly free cash flow year-on-year change?

Over the past year, TSHA quarterly free cash flow has changed by -$2.62M (-12.12%)

What is Taysha Gene Therapies, Inc. TTM free cash flow?

The current TTM free cash flow of TSHA is -$85.14M

What is the all-time high TTM free cash flow for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high TTM free cash flow is -$1.70M

What is Taysha Gene Therapies, Inc. TTM free cash flow year-on-year change?

Over the past year, TSHA TTM free cash flow has changed by -$5.70M (-7.17%)
On this page